Cizzle Biotechnology Holdings Plc (CIZ.L)
Stock analysis · LSE · Healthcare · Biotechnology
Market Cap
N/A
PE (TTM)
N/A
EPS (TTM)
N/A
Dividend Yield
N/A
Beta
-0.03
Day Range
N/A
52-wk Range
N/A
Avg Volume
N/A
Volume
N/A
Cizzle Biotechnology Holdings Plc (CIZ.L) is a publicly traded company in the Healthcare sector. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →Proprietary Signals
About Cizzle Biotechnology Holdings Plc
Cizzle Biotechnology Holdings Plc specializes in developing an advanced immunoassay diagnostic test. This innovative tool aims to identify the CIZ1B biomarker, facilitating the early detection of lung cancer. The company, previously known as Cizzle Biotechnology Limited, officially changed its corporate identity to Cizzle Biotechnology Holdings Plc in May 2021. Its main operational base is situated in London, United Kingdom.
Peers
Recent News
- No recent news available.
Related
Browse more tickers: sitemap